SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1y4c'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_B_DVAB8_0 (GRAMICIDIN A)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	3 / 3	TRP A 158 VAL A 259 TRP A 340	None None GLC A 372 (-3.6A)	1.28A	1c4dA-1y4cA: undetectable 1c4dB-1y4cA: undetectable	1c4dA-1y4cA: 3.17 1c4dB-1y4cA: 3.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 6	VAL A 8 VAL A 50 ILE A 60 ASN A 267	None	0.93A	1e06A-1y4cA: 0.0	1e06A-1y4cA: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7A_B_PFLB4001_1 (SERUM ALBUMIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 9	ILE A 9 LEU A 262 VAL A 293 GLY A 16 LEU A 284	None	1.25A	1e7aB-1y4cA: undetectable	1e7aB-1y4cA: 23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QU2_A_MRCA1993_2 (ISOLEUCYL-TRNA SYNTHETASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	3 / 3	GLU A 111 TRP A 230 LYS A 273	GLC A 371 (-2.9A) GLC A 371 ( 4.6A) None	1.23A	1qu2A-1y4cA: 3.1	1qu2A-1y4cA: 19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2434_1 (CHITINASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 6	GLU A 310 TYR A 307 ASP A 314 ARG A 316	None	1.50A	2a3bB-1y4cA: undetectable	2a3bB-1y4cA: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOH_C_FRDC305_2 (POL POLYPROTEIN PEPTIDE INHIBITOR)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 262 GLY A 289 ALA A 109 ILE A 108	None	0.84A	2aohB-1y4cA: undetectable	2aohB-1y4cA: 13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	ALA A 264 LEU A 280 PHE A 279 VAL A 293 GLY A 16	None	1.08A	2ve3A-1y4cA: undetectable	2ve3A-1y4cA: 22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 6	PHE A 258 ALA A 162 LEU A 247 PRO A 159	None	0.97A	3bgdA-1y4cA: undetectable	3bgdA-1y4cA: 19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 7	VAL A 110 GLY A 300 PRO A 229 LYS A 305	None	0.72A	3bjwC-1y4cA: undetectable	3bjwC-1y4cA: 12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 8	VAL A 110 GLY A 300 PRO A 229 LYS A 305	None	0.93A	3bjwA-1y4cA: undetectable	3bjwA-1y4cA: 12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_A_BEZA302_0 (DISULFIDE INTERCHANGE PROTEIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 6	PRO A 126 LEU A 147 ALA A 223 PRO A 125	None	1.25A	3gv1A-1y4cA: undetectable 3gv1C-1y4cA: undetectable	3gv1A-1y4cA: 13.56 3gv1C-1y4cA: 13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB301_0 (DISULFIDE INTERCHANGE PROTEIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 6	LEU A 147 ALA A 223 PRO A 125 PRO A 126	None	1.23A	3gv1A-1y4cA: undetectable 3gv1B-1y4cA: undetectable	3gv1A-1y4cA: 13.56 3gv1B-1y4cA: 13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	VAL A 343 GLY A 187 ALA A 188 LEU A 192 LEU A 160	None	1.06A	3hs6A-1y4cA: undetectable	3hs6A-1y4cA: 20.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	9 / 12	ASP A 14 LYS A 15 LYS A 42 GLU A 44 ALA A 63 ASP A 65 ARG A 66 GLU A 111 TRP A 230	GLC A 371 (-3.2A) GLC A 371 (-2.7A) None None GLC A 371 ( 3.2A) GLC A 372 (-2.8A) GLC A 372 (-3.8A) GLC A 371 (-2.9A) GLC A 371 ( 4.6A)	0.77A	3jyrA-1y4cA: 62.4	3jyrA-1y4cA: 70.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	6 / 7	ASN A 12 TRP A 62 GLU A 153 TYR A 155 MET A 330 TRP A 340	GLC A 371 (-4.4A) GLC A 372 (-4.3A) GLC A 372 ( 3.7A) GLC A 371 (-3.9A) GLC A 372 ( 4.3A) GLC A 372 (-3.6A)	0.22A	3jyrA-1y4cA: 62.4	3jyrA-1y4cA: 70.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 7	TRP A 62 TYR A 155 MET A 330 TRP A 340 ARG A 344	GLC A 372 (-4.3A) GLC A 371 (-3.9A) GLC A 372 ( 4.3A) GLC A 372 (-3.6A) None	0.58A	3jyrA-1y4cA: 62.4	3jyrA-1y4cA: 70.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 11	GLN A 365 ALA A 364 ALA A 162 GLY A 166 ALA A 188	None	1.00A	3mg0V-1y4cA: undetectable 3mg0W-1y4cA: undetectable	3mg0V-1y4cA: 19.11 3mg0W-1y4cA: 17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	VAL A 196 LEU A 160 GLY A 187 ALA A 188 LEU A 361	None	0.96A	3n8yB-1y4cA: 0.0	3n8yB-1y4cA: 21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	PHE A 156 GLY A 300 LEU A 299 GLU A 111 ALA A 231	None None None GLC A 371 (-2.9A) None	0.82A	3tbgB-1y4cA: undetectable	3tbgB-1y4cA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	PHE A 156 GLY A 300 LEU A 299 GLU A 111 ALA A 231	None None None GLC A 371 (-2.9A) None	0.81A	3tbgD-1y4cA: 1.4	3tbgD-1y4cA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	ALA A 231 TYR A 17 TYR A 210 ASN A 234 GLY A 228	None	1.35A	3vwqA-1y4cA: 0.0	3vwqA-1y4cA: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_A_SAMA501_1 (MNMC2)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 6	GLU A 308 ASP A 314 ASP A 287 ASN A 294	None	1.32A	3vywA-1y4cA: undetectable	3vywA-1y4cA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	GLU A 308 ASP A 314 ASP A 287 ASN A 294	None	1.32A	3vywD-1y4cA: undetectable	3vywD-1y4cA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L8F_D_MTXD301_1 (GAMMA-GLUTAMYL HYDROLASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 11	GLY A 600 GLY A 601 GLY A 602 ALA A 597 GLN A 609	None	0.97A	4l8fD-1y4cA: undetectable	4l8fD-1y4cA: 19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	ASN A 267 ALA A 51 GLY A 56 ASP A 14	None None None GLC A 371 (-3.2A)	0.95A	4n48A-1y4cA: undetectable	4n48A-1y4cA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 9	ALA A 264 ALA A 105 LEU A 103 LEU A 262 VAL A 261	None	1.17A	4or0B-1y4cA: 0.2	4or0B-1y4cA: 24.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z90_F_4LEF402_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 7	ALA A 621 LEU A 638 ALA A 582 ALA A 625	None	0.67A	4z90F-1y4cA: 7.1 4z90G-1y4cA: 7.0 4z90H-1y4cA: 6.3 4z90J-1y4cA: 7.0	4z90F-1y4cA: 18.91 4z90G-1y4cA: 18.91 4z90H-1y4cA: 18.91 4z90J-1y4cA: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z90_F_4LEF402_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 7	LEU A 579 ALA A 566 LEU A 583 ALA A 637	None	0.60A	4z90F-1y4cA: 7.1 4z90G-1y4cA: 7.0 4z90H-1y4cA: 6.3 4z90J-1y4cA: 7.0	4z90F-1y4cA: 18.91 4z90G-1y4cA: 18.91 4z90H-1y4cA: 18.91 4z90J-1y4cA: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z90_F_4LEF402_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 7	LEU A 583 ALA A 637 LEU A 579 ALA A 566	None	0.68A	4z90F-1y4cA: 7.1 4z90G-1y4cA: 7.0 4z90H-1y4cA: 6.3 4z90J-1y4cA: 7.0	4z90F-1y4cA: 18.91 4z90G-1y4cA: 18.91 4z90H-1y4cA: 18.91 4z90J-1y4cA: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z90_F_4LEF402_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 7	LEU A 607 ALA A 648 LEU A 611 ALA A 555	None	0.67A	4z90F-1y4cA: 7.1 4z90G-1y4cA: 7.0 4z90H-1y4cA: 6.3 4z90J-1y4cA: 7.0	4z90F-1y4cA: 18.91 4z90G-1y4cA: 18.91 4z90H-1y4cA: 18.91 4z90J-1y4cA: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z90_F_4LEF402_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 7	LEU A 634 ALA A 621 LEU A 638 ALA A 582	None	0.64A	4z90F-1y4cA: 7.1 4z90G-1y4cA: 7.0 4z90H-1y4cA: 6.3 4z90J-1y4cA: 7.0	4z90F-1y4cA: 18.91 4z90G-1y4cA: 18.91 4z90H-1y4cA: 18.91 4z90J-1y4cA: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HNZ_B_TA1B902_2 (TUBULIN BETA-2B CHAIN)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	3 / 3	LEU A 552 LEU A 611 ARG A 585	None	0.66A	5hnzB-1y4cA: undetectable	5hnzB-1y4cA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_A_PCFA1808_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 617 ALA A 621 LEU A 624 LEU A 583	None	0.85A	5vkqA-1y4cA: 5.1 5vkqD-1y4cA: 5.1	5vkqA-1y4cA: 15.21 5vkqD-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_A_PCFA1808_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 644 ALA A 648 LEU A 651 LEU A 556	None	0.74A	5vkqA-1y4cA: 5.1 5vkqD-1y4cA: 5.1	5vkqA-1y4cA: 15.21 5vkqD-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_B_PCFB1805_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 556 LEU A 644 ALA A 648 LEU A 651	None	0.74A	5vkqA-1y4cA: 5.1 5vkqB-1y4cA: 5.1	5vkqA-1y4cA: 15.21 5vkqB-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_B_PCFB1805_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 583 LEU A 617 ALA A 621 LEU A 624	None	0.85A	5vkqA-1y4cA: 5.1 5vkqB-1y4cA: 5.1	5vkqA-1y4cA: 15.21 5vkqB-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1806_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 556 LEU A 644 ALA A 648 LEU A 651	None	0.70A	5vkqB-1y4cA: 5.1 5vkqC-1y4cA: 5.1	5vkqB-1y4cA: 15.21 5vkqC-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1806_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 583 LEU A 617 ALA A 621 LEU A 624	None	0.82A	5vkqB-1y4cA: 5.1 5vkqC-1y4cA: 5.1	5vkqB-1y4cA: 15.21 5vkqC-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_D_PCFD1806_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	4 / 5	LEU A 556 LEU A 644 ALA A 648 LEU A 651	None	0.78A	5vkqC-1y4cA: 5.1 5vkqD-1y4cA: 5.1	5vkqC-1y4cA: 15.21 5vkqD-1y4cA: 15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	ALA A 188 ALA A 350 PHE A 339 SER A 368 VAL A 343	None	0.96A	5w4zA-1y4cA: undetectable	5w4zA-1y4cA: 10.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	6 / 12	ALA A 342 ALA A 338 GLY A 166 ALA A 188 PHE A 169 VAL A 181	None	1.44A	5w4zA-1y4cA: undetectable	5w4zA-1y4cA: 10.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	6 / 12	ALA A 342 ALA A 338 GLY A 166 ALA A 188 PHE A 169 VAL A 181	None	1.46A	5w4zB-1y4cA: undetectable	5w4zB-1y4cA: 10.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	3 / 3	TYR A 155 ASN A 227 LEU A 113	GLC A 371 (-3.9A) None None	0.80A	6b58A-1y4cA: 5.3	6b58A-1y4cA: 22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 12	GLN A 365 ALA A 364 ALA A 162 GLY A 166 ALA A 188	None	0.95A	6hwdH-1y4cA: undetectable 6hwdI-1y4cA: undetectable	6hwdH-1y4cA: 13.30 6hwdI-1y4cA: 11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	1y4c	MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN (Escherichia coli)	5 / 11	GLN A 365 ALA A 364 ALA A 162 GLY A 166 ALA A 188	None	0.95A	6hwdV-1y4cA: undetectable	6hwdV-1y4cA: 13.30

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C4D_B_DVAB8_0","GRAMICIDIN A","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",3,"TRP A 158;VAL A 259;TRP A 340","None;None;GLC A 372 (-3.6A)","1.28A","1c4dA-1y4cA:undetectable;1c4dB-1y4cA:undetectable","1c4dA-1y4cA:3.17;1c4dB-1y4cA:3.17"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"VAL A   8;VAL A  50;ILE A  60;ASN A 267","None","0.93A","1e06A-1y4cA:0.0","1e06A-1y4cA:14.68"],["1E7A_B_PFLB4001_1","SERUM ALBUMIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"ILE A   9;LEU A 262;VAL A 293;GLY A  16;LEU A 284","None","1.25A","1e7aB-1y4cA:undetectable","1e7aB-1y4cA:23.62"],["1QU2_A_MRCA1993_2","ISOLEUCYL-TRNA SYNTHETASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",3,"GLU A 111;TRP A 230;LYS A 273","GLC A 371 (-2.9A);GLC A 371 ( 4.6A);None","1.23A","1qu2A-1y4cA:3.1","1qu2A-1y4cA:19.78"],["2A3B_B_CFFB2434_1","CHITINASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"GLU A 310;TYR A 307;ASP A 314;ARG A 316","None","1.50A","2a3bB-1y4cA:undetectable","2a3bB-1y4cA:20.79"],["2AOH_C_FRDC305_2","POL POLYPROTEIN;PEPTIDE INHIBITOR","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 262;GLY A 289;ALA A 109;ILE A 108","None","0.84A","2aohB-1y4cA:undetectable","2aohB-1y4cA:13.59"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"ALA A 264;LEU A 280;PHE A 279;VAL A 293;GLY A  16","None","1.08A","2ve3A-1y4cA:undetectable","2ve3A-1y4cA:22.75"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"PHE A 258;ALA A 162;LEU A 247;PRO A 159","None","0.97A","3bgdA-1y4cA:undetectable","3bgdA-1y4cA:19.08"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"VAL A 110;GLY A 300;PRO A 229;LYS A 305","None","0.72A","3bjwC-1y4cA:undetectable","3bjwC-1y4cA:12.53"],["3BJW_G_SVRG506_1","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"VAL A 110;GLY A 300;PRO A 229;LYS A 305","None","0.93A","3bjwA-1y4cA:undetectable","3bjwA-1y4cA:12.53"],["3GV1_A_BEZA302_0","DISULFIDE INTERCHANGE PROTEIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"PRO A 126;LEU A 147;ALA A 223;PRO A 125","None","1.25A","3gv1A-1y4cA:undetectable;3gv1C-1y4cA:undetectable","3gv1A-1y4cA:13.56;3gv1C-1y4cA:13.56"],["3GV1_B_BEZB301_0","DISULFIDE INTERCHANGE PROTEIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 147;ALA A 223;PRO A 125;PRO A 126","None","1.23A","3gv1A-1y4cA:undetectable;3gv1B-1y4cA:undetectable","3gv1A-1y4cA:13.56;3gv1B-1y4cA:13.56"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"VAL A 343;GLY A 187;ALA A 188;LEU A 192;LEU A 160","None","1.06A","3hs6A-1y4cA:undetectable","3hs6A-1y4cA:20.07"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",9,"ASP A  14;LYS A  15;LYS A  42;GLU A  44;ALA A  63;ASP A  65;ARG A  66;GLU A 111;TRP A 230","GLC A 371 (-3.2A);GLC A 371 (-2.7A);None;None;GLC A 371 ( 3.2A);GLC A 372 (-2.8A);GLC A 372 (-3.8A);GLC A 371 (-2.9A);GLC A 371 ( 4.6A)","0.77A","3jyrA-1y4cA:62.4","3jyrA-1y4cA:70.85"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",6,"ASN A  12;TRP A  62;GLU A 153;TYR A 155;MET A 330;TRP A 340","GLC A 371 (-4.4A);GLC A 372 (-4.3A);GLC A 372 ( 3.7A);GLC A 371 (-3.9A);GLC A 372 ( 4.3A);GLC A 372 (-3.6A)","0.22A","3jyrA-1y4cA:62.4","3jyrA-1y4cA:70.85"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"TRP A  62;TYR A 155;MET A 330;TRP A 340;ARG A 344","GLC A 372 (-4.3A);GLC A 371 (-3.9A);GLC A 372 ( 4.3A);GLC A 372 (-3.6A);None","0.58A","3jyrA-1y4cA:62.4","3jyrA-1y4cA:70.85"],["3MG0_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"GLN A 365;ALA A 364;ALA A 162;GLY A 166;ALA A 188","None","1.00A","3mg0V-1y4cA:undetectable;3mg0W-1y4cA:undetectable","3mg0V-1y4cA:19.11;3mg0W-1y4cA:17.60"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"VAL A 196;LEU A 160;GLY A 187;ALA A 188;LEU A 361","None","0.96A","3n8yB-1y4cA:0.0","3n8yB-1y4cA:21.09"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"PHE A 156;GLY A 300;LEU A 299;GLU A 111;ALA A 231","None;None;None;GLC A 371 (-2.9A);None","0.82A","3tbgB-1y4cA:undetectable","3tbgB-1y4cA:21.34"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"PHE A 156;GLY A 300;LEU A 299;GLU A 111;ALA A 231","None;None;None;GLC A 371 (-2.9A);None","0.81A","3tbgD-1y4cA:1.4","3tbgD-1y4cA:21.34"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"ALA A 231;TYR A  17;TYR A 210;ASN A 234;GLY A 228","None","1.35A","3vwqA-1y4cA:0.0","3vwqA-1y4cA:20.70"],["3VYW_A_SAMA501_1","MNMC2","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"GLU A 308;ASP A 314;ASP A 287;ASN A 294","None","1.32A","3vywA-1y4cA:undetectable","3vywA-1y4cA:20.20"],["3VYW_D_SAMD401_1","MNMC2","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"GLU A 308;ASP A 314;ASP A 287;ASN A 294","None","1.32A","3vywD-1y4cA:undetectable","3vywD-1y4cA:20.20"],["4L8F_D_MTXD301_1","GAMMA-GLUTAMYL HYDROLASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"GLY A 600;GLY A 601;GLY A 602;ALA A 597;GLN A 609","None","0.97A","4l8fD-1y4cA:undetectable","4l8fD-1y4cA:19.49"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"ASN A 267;ALA A  51;GLY A  56;ASP A  14","None;None;None;GLC A 371 (-3.2A)","0.95A","4n48A-1y4cA:undetectable","4n48A-1y4cA:20.63"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"ALA A 264;ALA A 105;LEU A 103;LEU A 262;VAL A 261","None","1.17A","4or0B-1y4cA:0.2","4or0B-1y4cA:24.01"],["4Z90_F_4LEF402_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"ALA A 621;LEU A 638;ALA A 582;ALA A 625","None","0.67A","4z90F-1y4cA:7.1;4z90G-1y4cA:7.0;4z90H-1y4cA:6.3;4z90J-1y4cA:7.0","4z90F-1y4cA:18.91;4z90G-1y4cA:18.91;4z90H-1y4cA:18.91;4z90J-1y4cA:18.91"],["4Z90_F_4LEF402_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 579;ALA A 566;LEU A 583;ALA A 637","None","0.60A","4z90F-1y4cA:7.1;4z90G-1y4cA:7.0;4z90H-1y4cA:6.3;4z90J-1y4cA:7.0","4z90F-1y4cA:18.91;4z90G-1y4cA:18.91;4z90H-1y4cA:18.91;4z90J-1y4cA:18.91"],["4Z90_F_4LEF402_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 583;ALA A 637;LEU A 579;ALA A 566","None","0.68A","4z90F-1y4cA:7.1;4z90G-1y4cA:7.0;4z90H-1y4cA:6.3;4z90J-1y4cA:7.0","4z90F-1y4cA:18.91;4z90G-1y4cA:18.91;4z90H-1y4cA:18.91;4z90J-1y4cA:18.91"],["4Z90_F_4LEF402_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 607;ALA A 648;LEU A 611;ALA A 555","None","0.67A","4z90F-1y4cA:7.1;4z90G-1y4cA:7.0;4z90H-1y4cA:6.3;4z90J-1y4cA:7.0","4z90F-1y4cA:18.91;4z90G-1y4cA:18.91;4z90H-1y4cA:18.91;4z90J-1y4cA:18.91"],["4Z90_F_4LEF402_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 634;ALA A 621;LEU A 638;ALA A 582","None","0.64A","4z90F-1y4cA:7.1;4z90G-1y4cA:7.0;4z90H-1y4cA:6.3;4z90J-1y4cA:7.0","4z90F-1y4cA:18.91;4z90G-1y4cA:18.91;4z90H-1y4cA:18.91;4z90J-1y4cA:18.91"],["5HNZ_B_TA1B902_2","TUBULIN BETA-2B CHAIN","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",3,"LEU A 552;LEU A 611;ARG A 585","None","0.66A","5hnzB-1y4cA:undetectable","5hnzB-1y4cA:21.88"],["5VKQ_A_PCFA1808_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 617;ALA A 621;LEU A 624;LEU A 583","None","0.85A","5vkqA-1y4cA:5.1;5vkqD-1y4cA:5.1","5vkqA-1y4cA:15.21;5vkqD-1y4cA:15.21"],["5VKQ_A_PCFA1808_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 644;ALA A 648;LEU A 651;LEU A 556","None","0.74A","5vkqA-1y4cA:5.1;5vkqD-1y4cA:5.1","5vkqA-1y4cA:15.21;5vkqD-1y4cA:15.21"],["5VKQ_B_PCFB1805_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 556;LEU A 644;ALA A 648;LEU A 651","None","0.74A","5vkqA-1y4cA:5.1;5vkqB-1y4cA:5.1","5vkqA-1y4cA:15.21;5vkqB-1y4cA:15.21"],["5VKQ_B_PCFB1805_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 583;LEU A 617;ALA A 621;LEU A 624","None","0.85A","5vkqA-1y4cA:5.1;5vkqB-1y4cA:5.1","5vkqA-1y4cA:15.21;5vkqB-1y4cA:15.21"],["5VKQ_C_PCFC1806_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 556;LEU A 644;ALA A 648;LEU A 651","None","0.70A","5vkqB-1y4cA:5.1;5vkqC-1y4cA:5.1","5vkqB-1y4cA:15.21;5vkqC-1y4cA:15.21"],["5VKQ_C_PCFC1806_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 583;LEU A 617;ALA A 621;LEU A 624","None","0.82A","5vkqB-1y4cA:5.1;5vkqC-1y4cA:5.1","5vkqB-1y4cA:15.21;5vkqC-1y4cA:15.21"],["5VKQ_D_PCFD1806_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",4,"LEU A 556;LEU A 644;ALA A 648;LEU A 651","None","0.78A","5vkqC-1y4cA:5.1;5vkqD-1y4cA:5.1","5vkqC-1y4cA:15.21;5vkqD-1y4cA:15.21"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"ALA A 188;ALA A 350;PHE A 339;SER A 368;VAL A 343","None","0.96A","5w4zA-1y4cA:undetectable","5w4zA-1y4cA:10.05"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",6,"ALA A 342;ALA A 338;GLY A 166;ALA A 188;PHE A 169;VAL A 181","None","1.44A","5w4zA-1y4cA:undetectable","5w4zA-1y4cA:10.05"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",6,"ALA A 342;ALA A 338;GLY A 166;ALA A 188;PHE A 169;VAL A 181","None","1.46A","5w4zB-1y4cA:undetectable","5w4zB-1y4cA:10.05"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",3,"TYR A 155;ASN A 227;LEU A 113","GLC A 371 (-3.9A);None;None","0.80A","6b58A-1y4cA:5.3","6b58A-1y4cA:22.38"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"GLN A 365;ALA A 364;ALA A 162;GLY A 166;ALA A 188","None","0.95A","6hwdH-1y4cA:undetectable;6hwdI-1y4cA:undetectable","6hwdH-1y4cA:13.30;6hwdI-1y4cA:11.76"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","1y4c","MALTOSE BINDING PROTEIN FUSED WITH DESIGNED HELICAL PROTEIN","Escherichia coli",5,"GLN A 365;ALA A 364;ALA A 162;GLY A 166;ALA A 188","None","0.95A","6hwdV-1y4cA:undetectable","6hwdV-1y4cA:13.30"]]